<<>>>
TitleUrlVersionPublisher
Nodal Involvementhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.55320181002CancerLinQ Steward
COVID19 ICD10CM Value Set for Pulmonary Sarcoidosishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.301120200718Clinical Architecture
Immunocompromised Conditions I10http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.232820220210Oregon Urology Steward
Chronic Kidney Diseasehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.27620191023Change Healthcare Steward
Provider Evaluation EDhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.15.2.400220150410Mathematica
Uncorrected Chart Based Visual Acuity Screeninghttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1240.2017.3.1.101220170802Mathematica
Delivery of Singletonhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.9820210611TJC EH Steward
Interpretation of an Observation (High)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.201820230125CSTE Steward
Physical Therapy Evaluation (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.16920200430American Academy of Neurology Steward
Stage IIB or lower and limitedhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.6120231108CancerLinQ Steward
Renalhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.26120210121Joint Commission
Drug Withdrawal Syndrome Shttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.169520160331Lantana EH Steward
Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.172320230602CSTE Steward
Cesarean Section ICD10PCShttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.183520160331Lantana EH Steward
Pain Warranting Further Investigation for Prostate Cancerhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.32520230215Mathematica
COVID19 SNOMED Value Set for Chronic Heart Failurehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.629220220728Clinical Architecture
Appropriate Treatment of MSSA Beta Lactam Antibiotichttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1157.220171003IDSA Steward
Chagas Disease (Disorders) (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.165120230122CSTE Steward
Pesticide Related Illness (Tests for Pesticides)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.41620220119CSTE Steward
Referral to Hospice Carehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.11520201028American Society of Clinical Oncology Steward
Infectious conditionshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.181820200711Lewin EH Steward
COVID19 SNOMED Value Set for Polycystic Kidney Diseasehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.621720200710Clinical Architecture
Physical Activity Observation Questionshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.920231207HL7 C-CDA
Absence of Cervixhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.112.11.102520210915NCQA PHEMUR
External Beam Radiotherapyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.35520170810CancerLinQ Steward
Silicosis (Disorders) (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.36520181031CSTE Steward
Dihydrocodeine Schedule II and IIIhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.17020210223Lantana EH Steward
Enteral Medication Routehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.7420220720CDC NHSN
Eruptive Xanthomatosishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.55720210912HL7 Patient Care WG Steward
COVID19 SNOMED Value Set for Coronary Artery Thrombosishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.629620220728Clinical Architecture
<<>>>629630631632633<<>>>